Merck Obtains Approval of ZEPATIER™ in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review Pharmaceutical Investing
TapImmune Granted Fast Track Designation by FDA for Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer Genetics Investing
GenomeFIRST Awarded $400K Grant to Bring Genomic Information into Patients' Care Plans Genetics Investing
Stanford Researchers Publish Seminal Paper on Use of 10x Genomics’ GemCode™ Technology for Genomic Analysis Genetics Investing
Amarantus Reports Issuance of Chinese Patent Covering Use of MANF for the Treatment of Parkinson's Disease Biotech Investing
Human Longevity Inc. Acquires Stem Cell Banking from Celgene Cellular Therapeutics Genetics Investing
Full GenomesTM Corporation Partners with Novogene For Low-cost Whole Genome Ancestry Test Genetics Investing
DNAnexus and Sapio Sciences Team Up for Seamless Integration of Laboratory Information Management System and Cloud Bioinformatics Solution Cloud Investing
Predictive Technology Group, Inc. Announces First Members of Financial Advisory Board Genetics Investing